Search Results 1-10 of 17056 for GLP-1 drugs

  1. Diabetes drugs and weight loss - Mayo Clinic

    Tirzepatide (Mounjaro) is a similar kind of medicine called a dual-acting GLP-1/GIP agonist. It's also used to control blood sugar and can support weight loss.

  2. Prescription weight-loss drugs - Mayo Clinic

    FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety ...

  3. Genetic test predicts response to weight-loss drugs - Mayo Clinic News Network

    ... medications: a first-generation weight loss drug, phentermine-topiramate (brand name Qsymia), and a newer GLP-1 drug, liraglutide (Saxenda). They found that ...

  4. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... one or both of the medicines. Abiraterone Acetate ... drugs may be the best treatment for you ...

  5. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist. Action. Cause the release of insulin as blood sugar levels are rising ...

  6. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is ...

  7. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    ... GLP-1-based obesity medication semaglutide. No previous studies have examined whether hormone therapy might influence outcomes with tirzepatide. Dr ...

  8. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    Glucagon-like peptide 1 receptor agonists (GLP ... drugs, known as SGLT-2 inhibitors, DPP-4 ... 1 to 2 years or after two years of follow-up. This front ...

  9. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP ... drugs, surgical procedures or devices. Medical records research — uses ...

  10. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... one or both of the medicines. Abiraterone Acetate ... drugs may be the best treatment for you ...